475-31-0
基本信息
甘氨胆酸
3α,7α,12α-三羟基-5β-胆甾烷-24-羧酸-24-甘氨酰胺
N-[(3α,5β,7α,12α)-3,7,12-三羟基-24-氧代胆甾烷-24-基]甘氨酸
甘胆酸
甘胆酸水合物
甘膽酸
3ALPHA,7ALPHA,12ALPHA-TRIHYDROXY-5BETA-CHOLAN-24-OIC ACID N-[CARBOXYMETHYL]AMIDE
3ALPHA,7ALPHA,12ALPHA-TRIHYDROXY-5BETA-CHOLAN-24-OIC ACID N-(CARBOXYMETHYL) AMIDE, HYDRATE
5BETA-CHOLANIC ACID-3ALPHA,7ALPHA,12ALPHA-TRIOL 24-N-(CARBOXYMETHYL)-AMIDE
5-BETA-CHOLANIC ACID-3-ALPHA, 7-ALPHA, 12-ALPHA-TRIOL N-(CARBOXYMETHYL)-AMIDE
cholylglycine
CHOLYLGLYCINE HYDRATE
GLYCOCHOLIC
GLYCOCHOLIC ACID
GLYCOCHOLIC ACID HYDRATE
N-[3ALPHA,7ALPHA,12ALPHA-TRIHYDROXY-24-OXOCHOLAN-24-YL]GLYCINE
N-(3ALPHA,7ALPHA,12ALPHA-TRIHYDROXY-24-OXOCHOLAN-24-YL)-GLYCINE HYDRATE
n-(3-alpha,7-alpha,12-alpha-trihydroxycholan-24-oyl)glycine
[(3,7,12-Trihydroxy-24-oxocholan-24-yl)amino]acetic acid
Glycine, N-[(3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl]-
N-((3,5,7,12)-3,7,12-Trihydroxy-24-oxocholan-24-yl)glycine
N-Cholylglycine
glycocholic acid free acid
GLYCOCHOLIC ACID HYDRAT
Clycocholic acid
物理化学性质
外观性状 | 倍半水合物为结晶(5%乙醇)。熔点130℃。[α]23/D+30.8°(C7.5 95%乙醇);无水结晶熔点165-168℃。微溶于水,遇酸碱分解成甘氨酸和胆酸。 |
熔点 | 128°C |
沸点 | 568.76°C (rough estimate) |
密度 | 1.1336 (rough estimate) |
折射率 | 1.6000 (estimate) |
储存条件 | Refrigerator |
溶解度 | methanol: 0.1 g/mL, clear, colorless |
酸度系数(pKa) | 4.4(at 25℃) |
形态 | 固体 |
颜色 | 白色至灰白色 |
水溶解性 | 329.9mg/L(20 ºC) |
Merck | 13,4507 |
稳定性 | 吸湿性 |
InChIKey | RFDAIACWWDREDC-NSPZZGDONA-N |
LogP | 1.650 |
CAS 数据库 | 475-31-0(CAS DataBase Reference) |
NIST化学物质信息 | Glycocholic acid(475-31-0) |
安全数据
危险性符号(GHS) | GHS07 |
警示词 | 警告 |
危险性描述 | H302+H312+H332 |
防范说明 | P280 |
危险品标志 | N |
危险类别码 | R51/53 |
安全说明 | S61 |
危险品运输编号 | UN 3077 9/PG 3 |
WGK Germany | 3 |
应用领域
制备方法
常见问题列表
Human Endogenous Metabolite
|
Glycocholic acid (GC) increases the cytotoxicity of epirubicin, significantly increases the intracellular accumulation of epirubicin in Caco-2 cells and the absorption of epirubicin in rat small intestine, and intensified epirubicin-induced apoptosis. Glycocholic acid and epirubicin significantly reduce mRNA expression levels of human intestinal MDR1, MDR-associated protein (MRP)1, and MRP2; downregulate the MDR1 promoter region; suppress the mRNA expression of Bcl-2; induce the mRNA expression of Bax; and significantly increase the Bax-to-Bcl-2 ratio and the mRNA levels of p53, caspase-9 and -3. A combination of anticancer drugs with Glycocholic acid can control MDR via a mechanism that involves modulating P-gp and MRPs as well as regulating apoptosis-related pathways.
知名试剂公司产品信息
甘氨胆酸价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/11 | XW04753102 | 甘氨胆酸 | 475-31-0 | 1G | 75元 |
2024/11/11 | XW04753101 | 甘氨胆酸 | 475-31-0 | 250MG | 36元 |
2024/11/08 | HY-N1423 | 甘氨胆酸 Glycocholic acid | 475-31-0 | 50 mg | 350元 |